Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - World-news https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
-
Nine people were killed Saturday in a stampede at an El Salvador stadium where football fans had gathered to watch a local tournament, polic...
-
At around 9:30 am on Sunday, troops spotted a man approaching from the other side of the Line of Control (LoC) in the Silikote area of Uri. ...
-
Continuing his attacks against on media, US President Donald Trump on Sunday described himself as the "hardest working president",...
No comments:
Post a Comment